Free Trial

Takeda Pharmaceutical (TAK) Earnings Date, Estimates & Call Transcripts

$12.61
-0.06 (-0.47%)
(As of 06/20/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

TAK Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TAK Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Takeda Pharmaceutical Analyst EPS Estimates

Current Year EPS Consensus Estimate:$1.41 EPS
Next Year EPS Consensus Estimate: $1.53 EPS

TAK Earnings Date and Information

Takeda Pharmaceutical has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, July 25th, 2024 based off prior year's report dates.

Takeda Pharmaceutical Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
7/25/2024
(Estimated)
------- 
2/1/2024Q3 2024-$0.51+$0.51$0.79-$7.52 billion
10/26/2023Q2 2024-$0.50+$0.50$0.86-$6.94 billion
7/27/2023Q1 2024-$0.55+$0.55$0.89-$7.71 billion
5/11/2023Q4 2023-$0.39+$0.39$0.70-$7.23 billion
2/2/2023Q3 2023-$0.46+$0.46$0.63-$8.40 billion
10/27/2022Q2 2023-$0.52+$0.52$0.90-$7.26 billion  
7/28/2022Q1 2023-$0.56+$0.56$0.86-$7.51 billion
5/11/2022Q4 2022-$0.38+$0.38$0.79-$7.19 billion
2/3/2022Q3 2022-$0.54+$0.54$0.91-$8.21 billion    
10/28/2021Q2 2022-$0.45+$0.45$0.77-$7.67 billion
7/30/2021Q1 2022-$0.51+$0.51$0.44-$8.68 billion    
5/11/2021Q4 2021-$0.41+$0.41$0.23-$7.27 billion
2/4/2021Q3 2021-$0.56+$0.56$0.84-$8.01 billion
10/29/2020Q2 2021-$0.47+$0.47$0.93-$7.43 billion
7/31/2020Q1 2021-$0.57+$0.57$0.89-$7.46 billion
5/13/2020Q4 2020-$0.13+$0.13$0.25-$7.09 billion
2/4/2020Q3 2020-$0.53+$0.53$1.03-$7.90 billion  
10/31/2019Q2 2020-$0.59+$0.59$1.02-$7.56 billion  
7/31/2019Q1 2020-$0.56+$0.56$1.18-$7.73 billion

Takeda Pharmaceutical Earnings - Frequently Asked Questions

When is Takeda Pharmaceutical's earnings date?

Takeda Pharmaceutical has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, July 25th, 2024 based off last year's report dates. Learn more on TAK's earnings history.

How much revenue does Takeda Pharmaceutical generate each year?

Takeda Pharmaceutical (NYSE:TAK) has a recorded annual revenue of $28.20 billion.

How much profit does Takeda Pharmaceutical generate each year?

Takeda Pharmaceutical (NYSE:TAK) has a recorded net income of $994.06 million. TAK has generated $0.55 earnings per share over the last four quarters.

What is Takeda Pharmaceutical's price-to-earnings ratio?

Takeda Pharmaceutical (NYSE:TAK) has a trailing price-to-earnings ratio of 22.93 and a forward price-to-earnings ratio of 8.94. The price/earnings-to-growth ratio is 3.18.

What is Takeda Pharmaceutical's EPS forecast for next year?

Takeda Pharmaceutical's earnings are expected to grow from $1.41 per share to $1.53 per share in the next year, which is a 8.51% increase.


More Earnings Resources from MarketBeat

This page (NYSE:TAK) was last updated on 6/21/2024 by MarketBeat.com Staff

From Our Partners